Docs: Heart device might be breakthrough for muscular dystrophy

October 17, 2012
Docs: heart device might be breakthrough for muscular dystrophy
Ohio man among the first to receive the technology, aimed at preventing fatal heart failure.

(HealthDay)—A man with Duchenne muscular dystrophy who received a device to help his heart's left ventricle pump blood throughout his body could represent a breakthrough in the treatment of the disease, according to his doctors.

Jason Williams, 29, of Peebles, Ohio, is believed to be one of the first U.S. patients with Duchenne muscular dystrophy to receive an implanted ventricular assist device, the Cincinnati Children's Hospital Medical Center team said.

are mechanical pumps implanted in the chest to help a weakened blood to the rest of the body.

Eighty percent of boys and men with Duchenne muscular dystrophy die of , according to a medical center news release. Due to the severity of their , they are not typically candidates for or some other treatment options available to patients with other types of muscular dystrophy.

"This is a major milestone in the care of Duchenne muscular dystrophy," Dr. John Lynn Jefferies, director of the heart failure and ventricular assist device programs at the Cincinnati Children's Heart Institute, said in the news release. "This treatment offers the possibility to change the outcome and the lives of these young men in a significant way that has never been realized up until now."

Duchenne muscular dystrophy is an inherited disorder. It affects mostly males and many patients need a wheelchair before the age of 12. Patients with later stages of the disease experience severe difficulty breathing and , and many patients die in their late teens or early 20s.

Williams explained his decision to receive the ventricular assist device.

"I wanted to live longer with a better quality of life, and help other people—those with Duchenne facing heart failure and death," Williams said in the news release. "I hope that doctors and surgeons can learn from my surgery and my recovery and be able to offer this treatment to other men and boys with Duchenne."

Each year, about 2,500 people worldwide are born with Duchenne muscular dystrophy. By age 21, every Duchenne patient has a heart muscle disease called dilated cardiomyopathy.

Explore further: New breakthrough could help treat muscular dystrophy

More information: The U.S. National Human Genome Research Institute has more about Duchenne muscular dystrophy.


Related Stories

New breakthrough could help treat muscular dystrophy

August 13, 2012
A researcher in the Faculty of Medicine & Dentistry at the University of Alberta improved Duchenne muscular dystrophy symptoms in non-human lab models, using a new drug cocktail. The drug combination targets the “hot ...

Researchers review muscular dystrophy therapies

June 22, 2012
Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published ...

Recommended for you

Could this protein protect people against coronary artery disease?

November 17, 2017
The buildup of plaque in the heart's arteries is an unfortunate part of aging. But by studying the genetic makeup of people who maintain clear arteries into old age, researchers led by UNC's Jonathan Schisler, PhD, have identified ...

New model estimates odds of events that trigger sudden cardiac death

November 16, 2017
A new computational model of heart tissue allows researchers to estimate the probability of rare heartbeat irregularities that can cause sudden cardiac death. The model, developed by Mark Walker and colleagues from Johns ...

Popular e-cigarette liquid flavorings may change, damage heart muscle cells

November 16, 2017
Chemicals used to make some popular e-cigarette liquid flavorings—including cinnamon, clove, citrus and floral—may cause changes or damage to heart muscle cells, new research indicates.

Possible use for botulinum toxin to treat atrial fibrillation

November 16, 2017
From temporarily softening wrinkles to easing migraines, botulinum toxin has become a versatile medical remedy because of its ability to block nerve signals that can become bothersome or risky.

Proteome of the human heart mapped for the first time

November 15, 2017
A healthy heart beats about two billion times during a lifetime, thanks to the interplay of more than 10,000 proteins. Researchers from the Max Planck Institute of Biochemistry (MPIB) and the German Heart Centre at the Technical ...

First transcatheter implant for diastolic heart failure successful

November 15, 2017
Results presented today at the American Heart Association Scientific Sessions and published in Circulation show that a new device designed to treat diastolic heart failure is safe and effective. The first patient in the randomized, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.